Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples